Reaction
Stasis Dermatitis reporting signals
As of the last recalculation, Stasis Dermatitis appears in 677 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is CAPTOPRIL (PRR 45.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Captopril | 14 | 45.7 | 45.8 |
| Felodipine Extended-Release Tablets | 14 | 38.6 | 38.6 |
| Felodipine | 14 | 38.6 | 38.6 |
| Nebivolol | 14 | 27.6 | 27.6 |
| Torsemide | 28 | 27.1 | 27.1 |
| Candesartan | 29 | 26.1 | 26.1 |
| Metolazone | 9 | 24.9 | 25.0 |
| Pemetrexed Disodium | 25 | 20.9 | 20.9 |
| Pemetrexed | 13 | 19.0 | 19.0 |